Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Levosimendan In Ambulatory Heart Failure Patients

NCT04705337 is registered in ClinicalTrials.gov with Medical University of Bialystok as lead sponsor.

NCT NCT04705337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04705337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Levosimendan In Ambulatory Heart Failure Patients
Lead sponsor
Medical University of Bialystok
Phase
Phase 4
Overall status
Terminated
Start date
December 15, 2021
Completion date
August 15, 2024
Enrollment
70 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure new york heart association class iii, heart failure new york heart association class iv, heart failure with reduced ejection fraction, heart failure, systolic